Market Potential ProNova is targeting expanded global access to proton therapy with a compact, energy-efficient system. This creates sales opportunities with cancer centers and hospitals seeking advanced, lower-cost equipment and faster ROI.

Strategic Partnerships Recent collaborations and funding signals (seed financing, collaboration with HHTC, leadership appointments) indicate a momentum toward scalable deployments and potential channel partnerships with healthcare providers and integrators.

Innovation Advantage The emphasis on integrated imaging, precision positioning, superconducting magnets, and PET-based treatment verification positions ProNova to differentiate on performance, operational efficiency, and payer value, appealing to procurement teams evaluating total cost of ownership.

Customer Acquisition Active participation in industry events such as SEE Symposium and NPC 2026 suggests focus on thought leadership and awareness-building to accelerate conversations with potential hospital networks, oncology groups, and regional distributors.

Financial Readiness With existing revenue visibility and $40M in funding, there is a credible foundation for approaching financial committees at prospective purchasers, offering compelling business cases for capex financing, partnerships, or vendor financing models.